mk-287

MK-287 (L-680573) is a platelet activator (PAF) antagonist that effectively inhibates the binding of [3H]C18-PAF to human platelets, polynucleated white blood cells (PMN), and pulmonary membranes. May be used to treat asthma,

Sacituzumab tirumotecan(SKB264)是一种靶向TROP2(trophoblast cell surface antigen 2)的ADC(抗体-药物偶联物)，能够在TROP2阳性肿瘤细胞内释放有效载荷KL610023，一种有效的topoisomerase I抑制剂，诱导DNA损伤并导致细胞周期阻滞与凋亡，可用于非小细胞肺癌（NSCLC）和三阴性乳腺癌（TNBC）。